Device type · OCL
Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
OCL
Cardiovascular
Device class
Class II
FDA decisions since 2015
16
510(k), De Novo and PMA
Adverse event reports
47
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue
- Product code
- OCL
- Device class
- Class II
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 878.4400
- Specialty
- Cardiology, Electrophysiology
- FDA record
- Classification database entry for OCL
Latest FDA decisions
The 8 newest of 16 since 2015.
K252056 · Decided Jul 24, 2025 · 23 days after receipt
Device type: Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue (OCL) · General & Plastic Surgery
K234151 · Decided Aug 27, 2024 · 242 days after receipt
Device type: Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue (OCL) · General & Plastic Surgery
K221358 · Decided Dec 30, 2022 · 233 days after receipt
Device type: Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue (OCL) · General & Plastic Surgery
K223508 · Decided Dec 22, 2022 · 30 days after receipt
Device type: Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue (OCL) · General & Plastic Surgery
K210477 · Decided Jul 26, 2021 · 157 days after receipt
Device type: Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue (OCL) · General & Plastic Surgery
K211311 · Decided May 28, 2021 · 28 days after receipt
Device type: Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue (OCL) · General & Plastic Surgery
K200514 · Decided Jun 3, 2020 · 93 days after receipt
Device type: Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue (OCL) · General & Plastic Surgery
K193162 · Decided Dec 13, 2019 · 28 days after receipt
Device type: Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue (OCL) · General & Plastic Surgery
Reports received
47
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
28
60% of reports
Injury reports
16
34% of reports
Death reports
2
4.3% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 4 | 3 | 0 | 0 |
| Jan 24 | 0 | 1 | 0 | 0 |
| Feb 24 | 2 | 15 | 0 | 0 |
| Mar 24 | 1 | 4 | 1 | 0 |
| Apr 24 | 1 | 2 | 0 | 0 |
| May 24 | 0 | 2 | 0 | 0 |
| Jun 24 | 0 | 2 | 0 | 0 |
| Jul 24 | 1 | 3 | 0 | 0 |
| Aug 24 | 1 | 1 | 0 | 0 |
| Sep 24 | 1 | 1 | 1 | 0 |
| Oct 24 | 0 | 10 | 1 | 0 |
| Nov 24 | 3 | 2 | 0 | 0 |
| Dec 24 | 2 | 1 | 0 | 0 |
| Jan 25 | 4 | 5 | 0 | 0 |
| Feb 25 | 1 | 0 | 0 | 0 |
| Mar 25 | 1 | 1 | 0 | 0 |
| Apr 25 | 2 | 1 | 0 | 0 |
| May 25 | 3 | 3 | 0 | 0 |
| Jun 25 | 10 | 1 | 0 | 0 |
| Jul 25 | 3 | 2 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 1 | 0 | 0 | 0 |
| Oct 25 | 0 | 5 | 0 | 0 |
| Nov 25 | 1 | 1 | 0 | 0 |
| Dec 25 | 1 | 2 | 0 | 0 |
| Jan 26 | 1 | 4 | 2 | 0 |
| Feb 26 | 2 | 2 | 0 | 0 |
| Mar 26 | 1 | 2 | 0 | 0 |
| Apr 26 | 5 | 1 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 | 0 |
| Jul 26 | 9 | 1 | 0 | 0 |
| Aug 26 | 4 | 2 | 0 | 1 |
| Sep 26 | 1 | 0 | 0 | 0 |
| Oct 26 | 2 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- AtriCure25
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem17
- Obstruction of Flow13
- High impedance9
- Break6
- Separation Problem5
- Material Deformation3
- Crack1
- Fluid/Blood Leak1
- Positioning Problem1
- Temperature Problem1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions28
- Hemorrhage/Blood Loss/Bleeding10
- Cardiac Perforation7
- Device Embedded In Tissue or Plaque2
- Foreign Body In Patient2
- Insufficient Information1
- Ischemia Stroke1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1131-2022 · Started Apr 20, 2022
Reason given: Firm detected an increase in complaints related to fractured jaw tips of the Cardioblate Gemini-s.
Cause as FDA categorized it: Labeling design
- Cardioblate CryoFlex Surgical Ablation ConsoleOpen, Classified
Z-0273-2022 · Started Sep 27, 2021
Reason given: There is potential for intermittent electrical connectivity between the console and probe.
Cause as FDA categorized it: Process control
Z-0493-2021 · Started Oct 12, 2020
Reason given: There is a potential defect in the seals of the sterile barrier pouch used to package the CryoFlex disposables devices
Cause as FDA categorized it: Under Investigation by firm
Z-0494-2021 · Started Oct 12, 2020
Reason given: There is a potential defect in the seals of the sterile barrier pouch used to package the CryoFlex disposables devices
Cause as FDA categorized it: Under Investigation by firm
Z-0495-2021 · Started Oct 12, 2020
Reason given: There is a potential defect in the seals of the sterile barrier pouch used to package the CryoFlex disposables devices
Cause as FDA categorized it: Under Investigation by firm
Z-0496-2021 · Started Oct 12, 2020
Reason given: There is a potential defect in the seals of the sterile barrier pouch used to package the CryoFlex disposables devices
Cause as FDA categorized it: Under Investigation by firm
Z-1887-2019 · Started May 29, 2019
Reason given: The sterile package seal for the Epi-Sense Guided Coagulation System may be compromised, and has a worst-case reasonable harm of infection if used.
Cause as FDA categorized it: Process control
Z-0829-2019 · Started Jan 22, 2019
Reason given: There is a potential for patients undergoing ablation to experience an elevated risk for TE; during stand-alone off-pump procedures where cardio pulmonary bypass (CPB) was not utilized.
Cause as FDA categorized it: Unknown/Undetermined by firm
Showing the 8 newest of 17 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.